10-K · April 30, 2026
Forian Inc.'s 10-K filing reveals a challenging financial landscape with varied earnings performance over the previous quarters, showcasing inflections in revenue and EPS, particularly with a significant drop in…
Earnings analysis · 10-Q
FORA earnings analysis
Filed May 14, 2026 · Our reading of the company's report
The latest report
Forian Inc.'s Q1 2026 results indicate a continuation of revenue decline, with total revenues falling to $6.85M, a decrease of $205K or 2.9% from Q1 2025. The operating loss widened significantly to $3.49M compared to a…
Read full summary
Forian Inc.'s Q1 2026 results indicate a continuation of revenue decline, with total revenues falling to $6.85M, a decrease of $205K or 2.9% from Q1 2025. The operating loss widened significantly to $3.49M compared to a loss of $1.39M a year prior, largely driven by increased costs of revenues and strategic expenses. Despite this, the company still possesses a robust liquidity position with $30.95M in cash as of the reporting date.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.14
- Gross margin
- 29%
What stood out
-
Revenue Decline
Total revenue for Q1 2026 was $6.85M, down $205K or 2.9% from $7.06M in Q1 2025.
-
Widened Operating Loss
Operating loss widened to $3.49M compared to a loss of $1.39M in the previous year.
-
Drop in Gross Margin
Gross profit margin decreased to 29% in Q1 2026, down from 56% in Q1 2025.
-
Increased R&D Spending
R&D expenses increased to $961K, up $355K from $606K in Q1 2025.
-
Decreased General & Administrative Costs
General and administrative expenses fell by $832K to $2.45M from $3.28M year-over-year.
-
Strong Cash Position
Cash balance grew to $30.95M, showing solid liquidity for future operations.
What to watch
-
Dependence on Client Contracts
The decrease in revenue was partly due to contract terminations by health science customers, highlighting vulnerability in client dependency.
-
Increased Operating Losses
The operating loss has expanded significantly, with a $3.49M loss indicating ongoing profitability challenges.
-
Regulatory and Compliance Risks
Continued disclosure of material weaknesses in internal controls could hinder investor confidence.
Management's outlook
Management did not provide numeric guidance, suggesting uncertainty in future earnings.
Earlier filings 4
10-K · March 27, 2026
Forian describes a strategy focused on data factory-driven, subscription and services-based information products for healthcare, life sciences and (post‑Kyber) financial services clients, emphasizing a large linked…
10-Q · November 14, 2025
Forian reported Q3 revenue of $7,762,183, up from $4,686,312 in Q3 2024, with gross margin of 51.6% and an operating loss of $469,885 (‑6.1% of revenue). Net loss narrowed to $151,220 (basic/diluted loss per share…
10-Q · August 14, 2025
Forian reported strong top-line acceleration in Q2 2025 with revenue of $7,476,140, up from $4,777,101 in Q2 2024 (+56.5%). The company swung to operating income of $46,076 (0.6% operating margin) from an operating loss…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.